University of Vermont
University of Vermont
Colchester, Vermont, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| American Lung Association (ALA) Lung Health Cohort | lung disorder, respiratory system disorder | Recruiting | Not stated | 2026-09-23 | NCT04543461 | |
| Sinus Disease in Young Children With Cystic Fibrosis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Neurologic Manifestations, Olfactory Impairment, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, anosmia, cystic fibrosis, disease, hereditary disease, lung disorder, nervous system disorder, pancreas disorder, respiratory system disorder | Recruiting | Not stated | 2026-09-10 | NCT06191640 | |
| Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, allergic disease, chronic obstructive pulmonary disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-09-04 | NCT07059091 | |
| Cardiovascular Health Study (CHS) | Nutritional and Metabolic Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congestive heart failure, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, hypertensive disorder, metabolic disease, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Not stated | 2026-02-03 | NCT00005133 |